Why is Panacea Biotec falling/rising?

As of 25-Aug, Panacea Biotec Ltd is experiencing a decline in its stock price, currently at Rs 401.50, which represents a decrease of Rs 4.9 or 1.21%. The stock has underperformed its sector today by 1.62%, and it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, the stock has shown a negative return of 3.77% over the past month and 3.18% year-to-date, despite a significant increase of 98.37% over the past year. The company's operating losses and weak long-term fundamental strength, highlighted by a poor EBIT to Interest ratio and declining operating profit, contribute to the stock's downward movement. Furthermore, the low cash reserves and lack of domestic mutual fund investment indicate a lack of confidence in the company's future performance.
In the broader market context, the Sensex has shown a positive return of 0.45% over the past week and 4.48% year-to-date, contrasting with Panacea Biotec's negative short-term performance. This divergence suggests that while the overall market is gaining, Panacea Biotec is struggling, which may be exacerbated by its weak financial indicators and declining investor participation. The stock's liquidity remains adequate for trading, but the significant drop in delivery volume further reflects waning investor interest, which could be a contributing factor to its current price decline.